Conditional Placing to Raise Gross Proceeds of £600,000 (US$0.73 million)

By Motif October 2, 2019 No Comments

Conditional Placing to Raise Gross Proceeds of £600,000 (US$0.73 million)

https://www.motifbio.com/wp-content/uploads/2019/10/MTFB-Conditional-Placing-02.10.19.pdf

Get MotifBio Email Alerts Subscribe

About Us

Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.

Navigation

About Motif
Iclaprim
Investors
News Releases
Contact Us

Contact Us

Motif Bio plc
201 Temple Chambers
3-7 Temple Avenue
London EC4Y 0DT
United Kingdom

Motif BioSciences Inc.
125 Park Avenue, 25th Floor
New York, NY 10017
United States
General: info@motifbio.com
Investors: ir@motifbio.com

About
Development Programs
Partnering
Investors
Contact

Conditional Placing to Raise Gross Proceeds of £600,000 (US$0.73 million)